FDA orphan drug designation: treatment of thromboangiitis obliterans
All entries for: Shanghai CirCode Biomed Co. Ltd.
October 23, 2025
Shanghai CirCode Biomed Co. Ltd.
Orphan Drug Designation
Disease Area: Rare Diseases
FDA orphan drug designation: treatment of thromboangiitis obliterans
